Gerber introduces Good Start Soothe formula
FLORHAM PARK, N.J. — Gerber has introduced a new infant formula that is designed to reduce excessive crying and colic in healthy infants.
Gerber Good Start Soothe formula is milk-based and contains the probiotic L. reuteri, which aims to reduce crying time among colicky babies. The formula features the Comfort Proteins Advantage, which makes it easy for babies to digest, and also has a carbohydrate blend with 30% lactose for fussiness and gas in infants with lactose intolerance.
"Anyone who has experienced a crying baby with colic will understand the significance of this innovation," Gerber medical director Jose Saavedra said. "Now we can offer parents a solution for excessive crying and colic in a formula that meets the nutritional needs of babies."
In related news, Gerber plans to launch Gerber Soothe colic relief drops with L. reuteri later this year. This probiotic supplement will join Gerber Good Start Soothe formula to offer parents more options to help provide relief to babies with excessive crying and colic.
Orville Redenbacher expands popcorn lineup
MISSISSAUGA, Ontario — Orville Redenbacher has introduced four new gourmet popcorn varieties.
Orville’s ready to eat popcorn adds the tangy taste of dill, the zesty spice of chipotle, the sweet and savoury decadence of kettle corn and the sharp bite of white cheddar to the iconic popcorn brand’s list of innovative products. The new products include Orville Redenbacher’s sweet and salty kettlecorn; white cheddar gourmet popcorn; white cheddar chipotle gourmet popcorn and dill pickle gourmet popcorn.
"Orville Redenbacher spent decades testing 30 thousand different types of corn before he settled on the one that made the perfect popcorn back in 1965," Orville Redenbacher Canada senior brand manager Annabelle Nogueira said. "Today people want a snack they can grab and enjoy on the go. They want full flavor and variety. Orville Redenbacher ready-to-eat gourmet popcorn will satisfy any snack craving, and as Orville always said, you’ll like it better, or our name isn’t Orville Redenbacher."
FDA approves Perrigo acne treatment
ALLEGAN, Mich. — The Food and Drug Administration has approved an acne treatment made by Perrigo, the drug maker said Wednesday.
Perrigo announced the approval of clindamycin phosphate and benzoyl peroxide topical gel in the 1.2%/5% strength. The drug is a generic version of Duac, made by GlaxoSmithKline subsidiary Stiefel. Perrigo’s 2009 regulatory application for the drug included a paragraph IV certification, a legal assertion that the branded drug’s patent protection is invalid, unenforceable or won’t be infringed; the approval entitles Perrigo’s generic to 180 days of market exclusivity in which to directly compete with the branded version.
Duac has annual sales of about $130 million, according to Wolters Kluwer Health.